ホーム › 非小細胞肺癌 › ニュージャージー › Clifton
Clifton、NJにおける非小細胞肺癌の臨床試験
Cliftonとその周辺地域（約30マイル以内）の拠点で、非小細胞肺癌に関する24件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
A Study of ZW251 in Participants With Advanced Solid Tumors
被験者募集中第1相
- Hackensack University Medical Center, Hackensack · 7マイル先
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #105, Hackensack · 7マイル先
A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007)
被験者募集中第3相
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0152), Hackensack · 7マイル先
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
被験者募集中第3相
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7マイル先
A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer
被験者募集中第2相
- Hackensack University Medical Center, Hackensack · 7マイル先
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
被験者募集中第1/2相
- Hackensack University Medical Center, Hackensack · 7マイル先
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7マイル先
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
被験者募集中第1/2相
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7マイル先
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
被験者募集中第1相
- Hackensack University Medical Center, Hackensack · 7マイル先
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
被験者募集中第1/2相
- Hackensack University Medical Center, Hackensack · 7マイル先
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
被験者募集中第1/2相
- Hackensack University Medical Center, Hackensack · 7マイル先
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
被験者募集中第2/3相
- John Theurer Cancer Center, Hackensack · 7マイル先
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
被験者募集中第2相
- Hackensack Meridian Health, Hackensack · 7マイル先
Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]
被験者募集中第3相
- John Theurer Cancer Center at Hackensack University Medical Center ( Site 0035), Hackensack · 7マイル先
A Study of ASP2998 Given by Itself and Given With Standard Therapies in People With Solid Tumors
被験者募集中第1/2相
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7マイル先
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
被験者募集中第1/2相
- John Theurer Cancer Center at Hackensack UMC, Hackensack · 7マイル先
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
被験者募集中第1相
- John Theurer Cancer Ctr at Hackensack Univ. Med Ctr., Hackensack · 7マイル先
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
被験者募集中第1/2相
- John Theurer Cancer Center, Hackensack · 7マイル先
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
被験者募集中第1相
- Hackensack University Medical Center - John Theurer Cancer Center, Hackensack · 7マイル先
A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors
被験者募集中第1相
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7マイル先
A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation
被験者募集中第1相
- Hackensack University Medical Center, Hackensack · 7マイル先
A Study to Evaluate the Safety, Tolerability, and Efficacy of Escalating Doses of BMS-986463 in Participants With Select Advanced Malignant Tumors.
被験者募集中第1相
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack · 7マイル先
A Study of LY4175408 in Participants With Advanced Cancer
被験者募集中第1相
- John Theurer Cancer Center At Hackensack UMC, Hackensack · 7マイル先
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
被験者募集中第1相
- Hackensack University Medical Center, Hackensack · 7マイル先
RAPA-201 Therapy of Solid Tumors
被験者募集中第1/2相
- Hackensack University Medical Center, Hackensack · 7マイル先
他の都市における非小細胞肺癌の試験
- Houston, TX145件の研究
- New York City, NY121件の研究
- Arlington, VA104件の研究
- Nashville, TN97件の研究
- Boston, MA90件の研究
- Los Angeles, CA87件の研究
- St. Louis, MO73件の研究
- Chicago, IL61件の研究
- Baltimore, MD60件の研究
- San Antonio, TX59件の研究
- Columbus, OH57件の研究
- Washington, DC55件の研究
Cliftonにおける他の研究
- がん（全種類）15件の研究
- 多発性骨髄腫14件の研究
- 転移性癌12件の研究
- 急性骨髄性白血病12件の研究
- 乳がん12件の研究
- 前立腺がん12件の研究
- 卵巣がん11件の研究
- 肺がん10件の研究
- 大腸癌8件の研究
- 頭頸部扁平上皮癌8件の研究
- 子宮内膜がん8件の研究
- 心不全8件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。